Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3737 | 720 | 43.3 | 91% |
Classes in level above (level 3) |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 19247 | 449 | PIM 2//PIM 1//PIM 3 |
| 24097 | 271 | TCTP//TRANSLATIONALLY CONTROLLED TUMOR PROTEIN//TRANSLATIONALLY CONTROLLED TUMOR PROTEIN TCTP |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PIM 2 | Author keyword | 68 | 100% | 3% | 22 |
| 2 | TRANSLATIONALLY CONTROLLED TUMOR PROTEIN | Author keyword | 44 | 71% | 5% | 35 |
| 3 | TCTP | Author keyword | 42 | 64% | 6% | 41 |
| 4 | PIM 1 | Author keyword | 40 | 51% | 8% | 56 |
| 5 | PIM 3 | Author keyword | 35 | 89% | 2% | 16 |
| 6 | PIM KINASES | Author keyword | 25 | 73% | 3% | 19 |
| 7 | PIM KINASE | Author keyword | 21 | 75% | 2% | 15 |
| 8 | TRANSLATIONALLY CONTROLLED TUMOR PROTEIN TCTP | Author keyword | 21 | 85% | 2% | 11 |
| 9 | PIM1 KINASE | Author keyword | 18 | 89% | 1% | 8 |
| 10 | PIM 1 KINASE | Author keyword | 13 | 69% | 2% | 11 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PIM 2 | 68 | 100% | 3% | 22 | Search PIM+2 | Search PIM+2 |
| 2 | TRANSLATIONALLY CONTROLLED TUMOR PROTEIN | 44 | 71% | 5% | 35 | Search TRANSLATIONALLY+CONTROLLED+TUMOR+PROTEIN | Search TRANSLATIONALLY+CONTROLLED+TUMOR+PROTEIN |
| 3 | TCTP | 42 | 64% | 6% | 41 | Search TCTP | Search TCTP |
| 4 | PIM 1 | 40 | 51% | 8% | 56 | Search PIM+1 | Search PIM+1 |
| 5 | PIM 3 | 35 | 89% | 2% | 16 | Search PIM+3 | Search PIM+3 |
| 6 | PIM KINASES | 25 | 73% | 3% | 19 | Search PIM+KINASES | Search PIM+KINASES |
| 7 | PIM KINASE | 21 | 75% | 2% | 15 | Search PIM+KINASE | Search PIM+KINASE |
| 8 | TRANSLATIONALLY CONTROLLED TUMOR PROTEIN TCTP | 21 | 85% | 2% | 11 | Search TRANSLATIONALLY+CONTROLLED+TUMOR+PROTEIN+TCTP | Search TRANSLATIONALLY+CONTROLLED+TUMOR+PROTEIN+TCTP |
| 9 | PIM1 KINASE | 18 | 89% | 1% | 8 | Search PIM1+KINASE | Search PIM1+KINASE |
| 10 | PIM 1 KINASE | 13 | 69% | 2% | 11 | Search PIM+1+KINASE | Search PIM+1+KINASE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TCTP | 92 | 79% | 8% | 58 |
| 2 | BAD MEDIATED APOPTOSIS | 90 | 87% | 6% | 45 |
| 3 | PROTOONCOGENE PIM 1 | 53 | 95% | 3% | 18 |
| 4 | PHOSPHORYLATES BAD | 44 | 88% | 3% | 21 |
| 5 | CONTROLLED TUMOR PROTEIN | 29 | 39% | 8% | 58 |
| 6 | HISTAMINE RELEASING FACTOR | 26 | 34% | 9% | 64 |
| 7 | ANTIAPOPTOTIC ACTIVITY | 25 | 52% | 5% | 34 |
| 8 | SERINE THREONINE KINASE ACTIVITY | 19 | 76% | 2% | 13 |
| 9 | SERINE THREONINE KINASE PIM 1 | 17 | 70% | 2% | 14 |
| 10 | E MU MYC | 15 | 39% | 4% | 31 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The PIM Family of Serine/Threonine Kinases in Cancer | 2014 | 15 | 154 | 80% |
| Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities | 2013 | 27 | 140 | 83% |
| PIM kinase (and Akt) biology and signaling in tumors | 2015 | 1 | 111 | 65% |
| PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers | 2010 | 107 | 139 | 74% |
| For better or for worse: the role of Pim oncogenes in tumorigenesis | 2011 | 119 | 168 | 59% |
| Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update | 2014 | 5 | 37 | 97% |
| TCTP as therapeutic target in cancers | 2014 | 5 | 92 | 72% |
| PIM1 kinase as a target for cancer therapy | 2012 | 28 | 118 | 68% |
| The PIM kinases in hematological cancers | 2012 | 21 | 156 | 65% |
| Pim kinase inhibitors: a survey of the patent literature | 2010 | 35 | 61 | 61% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CANC MICROENVIRONM PROGRAM | 6 | 71% | 0.7% | 5 |
| 2 | CELL SIGNALLING DRUG DISCOVERY | 4 | 75% | 0.4% | 3 |
| 3 | TUMOR INTEGRAT MED | 3 | 50% | 0.6% | 4 |
| 4 | GENEVA PROTEOM | 2 | 67% | 0.3% | 2 |
| 5 | MOL BIOREGULAT | 1 | 10% | 1.8% | 13 |
| 6 | EXPT TCM | 1 | 100% | 0.3% | 2 |
| 7 | OSPED CIRCOLO BUSTO ARSIZIO | 1 | 50% | 0.3% | 2 |
| 8 | PANCREAS HEPATOBILIARY | 1 | 100% | 0.3% | 2 |
| 9 | THER EUT PROT DISCOVERY | 1 | 100% | 0.3% | 2 |
| 10 | ABO AKAD UNIV | 1 | 18% | 1.0% | 7 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000014854 | STAT3//INTERLEUKIN 7//SOCS |
| 2 | 0.0000012225 | PROTEIN KINASE CK2//CASEIN KINASE 2//CK2 |
| 3 | 0.0000008867 | PTEN//MTOR//LHERMITTE DUCLOS DISEASE |
| 4 | 0.0000008800 | IRES//TRANSLATION INITIATION//EIF4E |
| 5 | 0.0000008718 | ASTROCYTE ELEVATED GENE 1//AEG 1//DREF |
| 6 | 0.0000008451 | ID 1//NRSF//MYC |
| 7 | 0.0000008199 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
| 8 | 0.0000007236 | 14 3 3 PROTEINS//14 3 3 SIGMA//14 3 3 |
| 9 | 0.0000007179 | WHITE SPOT SYNDROME VIRUS//WSSV//POLYDNAVIRUS |
| 10 | 0.0000006515 | CELL PENETRATING PEPTIDE//CELL PENETRATING PEPTIDES//PROTEIN TRANSDUCTION DOMAINS |